A Clinical Study of Enlicitide in Participants With Severe Renal Impairment (MK-0616-032)

Clinical trial NCT06643377 · COMPLETED

Trial details

NCT number: NCT06643377
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Renal Impairment

Start date: 2024-11-22
Primary completion: 2025-06-25
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.